Trials / Recruiting
RecruitingNCT06864897
The 10-year Follow-up of the Delta-TT Trial.
The 10-year Follow-up of the Delta-TT Trial: Stability of the Delta-TT Cup with Polyethylene Insert Compared to the Delta-TT Cup with Ceramic Insert.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (estimated)
- Sponsor
- JointResearch · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This 10-year follow-up study aims to further investigate long-term migration patterns of the uncemented Delta-TT cup and H-MAX S stem, comparing outcomes between ceramic and polyethylene liners. Given the predictive value of early RSA migration patterns at the 2-year mark for identifying implants at risk of aseptic loosening, we hypothesize that the Delta-TT cup will demonstrate good stability at the 10-year postoperative mark. Besides, it is hypothesized that migration of Delta TT-cups is comparable between ceramic and polyethylene liners. The primary objective of this study is to measure the long-term stability of the Delta TT cup, combined with either a ceramic or cross-linked polyethylene liner, by means of RSA at 10-years postoperatively. Secondary objectives are to measure long-term stability of the H-MAX S stem, by means of RSA at 10-year postoperatively. Furthermore the study aims to measure implant survival rates and patient-reported outcomes for both the Delta-TT cup and H-MAX S stem, comparing outcomes between the ceramic and polyethylene group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Total hip prothesis | Total hip prothesis with a Delta-TT cup, H MAX S Stem and a ceramic liner |
| DEVICE | Total hip prosthesis | Total hip prosthesis with a Delta TT cup, H MAX S stem and polyethylene liner |
Timeline
- Start date
- 2024-10-10
- Primary completion
- 2026-05-01
- Completion
- 2029-05-01
- First posted
- 2025-03-07
- Last updated
- 2025-03-14
Locations
1 site across 1 country: Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06864897. Inclusion in this directory is not an endorsement.